Emsere

Leiden, Netherlands
VISIT WEBSITE
Emsere is a leading global clinical trial solutions partner specializing in medical equipment rental, supplies, and logistics. Formerly known as MediCapital Rent and MediRent, the company has over 25 years of expertise in managing the complex equipment needs of clinical trials. They provide a comprehensive range of services including equipment sourcing, calibration, global distribution, and asset management to ensure trials run effortlessly from startup to completion. The company serves a blue-chip client base, including six of the top 10 global pharmaceutical companies and seven of the top 10 Contract Research Organizations (CROs). Emsere operates a global network with distribution centers in the Netherlands and the United States, supporting trials in over 100 countries. Their portfolio includes more than 13,000 pieces of equipment, ranging from infusion pumps and centrifuges to advanced cardiovascular and respiratory monitoring devices.
CLASSIFICATION
Company Type:CRO
Industry:Medical Devices & Equipment
Sub-Industry:Clinical Trial Equipment & Logistics
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:1996
Ownership:private
Status:operating
FUNDING
Stage:Acquired
Investors:Antin Infrastructure Partners, Gryphion
PIPELINE
Stage:Commercial
Active Trials:400
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Antin Infrastructure Partners (Pending closing Q1 2026)
Acquired By:Antin Infrastructure Partners (2026-01-01)
Subsidiaries:Emsere USA
Key Partnerships:Antin Infrastructure Partners (Investment partner), Gryphion (Previous investment platform)
COMPETITION
Position:Leader
Competitors:Ancillare, LP, Woodley Equipment Company Ltd., Thermo Fisher Scientific, Quipment SAS, Myonex, Yourway, Marken (UPS)
LEADERSHIP
Key Executives:
Patrice Gerard - CEO
Jon Raven - Chief Commercial Officer
Pierre Otto - CFO/COO
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Emsere. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.